Astellas Submits New Drug Application for Zolbetuximab in Japan
Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers
TOKYO, June 9, 2023 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE: 4503, Presid... Biopharmaceuticals, Oncology, Regulatory Astellas Pharma, zolbetuximab, gastric cancer, gastroesophageal cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Japan Health | Marketing | New Drug Applications | Pharmaceuticals